SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: StockDung1/13/2010 4:33:36 PM
1 Recommendation   of 5582
 
Colbert cynically observed:

"I cannot for the life of me understand why the FDA would crack down on an unregulated heavy metal that you spray in your nose that can cause permanent damage."

About Zicam's developer, Robert Steven Davidson, Colbert stated that he:

"got his PhD from the American University of Asturias, an unaccredited and now-defunct university in Spain. The American University of Asturias is the Harvard of fake schools. It's even better than 'Altered State' and the 'Beerniversity of Drinkachusetts'. And just five years later, Davidson got his Bachelor's degree from the on-line virtual school, Excelsior College. That's right, he got his PhD first. Getting your BA before your PhD is your dad's way of doing things, just like researching your medicine's side-effects before you release it."

The Washington Post article "The Men Behind Zicam" stated that the health product's co-developers "have unusual backgrounds" and confirms the backstory of Davidson receiving his doctorate from a "diploma mill". The other patent holder, Charles Hensley, a professor at the Cleveland Chiropractic College "recently received a warning letter from the [FDA] about the sale over the Internet of an unapproved drug his company makes to treat bird flu" and "previously developed a weight-loss remedy that involves sniffing 'specially developed aromas'." Interestingly, the article pointed out that Davidson "declined to discuss whether any safety questions arose during Zicam's development and testing."

ottawaskeptics.org
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News